# Phase 2 Stress Disorders, Post-Traumatic trials: 55 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 55 trials in phase 2 for Stress Disorders, Post-Traumatic that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 2 Stress Disorders, Post-Traumatic trials: 55 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 3 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-2/stress-disorders-post-traumatic

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 55
- Recruiting or not yet: 55
- Read on: November 19, 2026

## Trials

The 25 newest of 55, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 9, 2026 | NCT07927036 | Enhancing the Effect of Stellate Ganglion Block in the Treatment of PTSD: Bupivacaine vs Bupivacaine + Ketamine | The Royal's Institute of Mental Health Research | Phase 2 | Not yet recruiting | Posttraumatic Stress Disorder (PTSD) | 126 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07927036) |
| October 29, 2026 | NCT07904000 | Written Exposure Therapy Plus Adjunctive Methylphenidate Treatment for Veterans With PTSD | VA Office of Research and Development | Phase 2 | Not yet recruiting | PTSD - Post Traumatic Stress Disorder | 138 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07904000) |
| October 9, 2026 | NCT07868536 | Post-traumatic Estradiol Administration and Care Evaluation (PEACE) | University of North Carolina, Chapel Hill | Phase 2 | Not yet recruiting | Chronic Musculoskeletal Pain, Sexual Assault, Posttraumatic Stress Disorder (PTSD) | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07868536) |
| October 1, 2026 | NCT07852728 | HBOT Effects on First Responders' Cognition and Well-Being | Sponsor not shown (see the record) | Phase 2 | Recruiting | Traumatic Brain Injury, PTSD - Post Traumatic Stress Disorder, Anxiety, Depression, Post Concussion Symptoms | 54 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07852728) |
| September 30, 2026 | NCT07849465 | Hyperbaric Oxygen Therapy for Veterans With TBI and PCS: A Biomarker Study | Sponsor not shown (see the record) | Phase 2 | Recruiting | Traumatic Brain Injury (TBI) Patients, Post Concussive Symptoms, PTSD | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07849465) |
| August 28, 2026 | NCT07792538 | Psilocybin-Assisted Psychotherapy for Veterans With PTSD | ARQ National Psychotrauma Centre | Phase 2 | Not yet recruiting | Posttraumatic Stress Disorder (PTSD) | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07792538) |
| August 20, 2026 | NCT07777380 | ONE-P TMS Military Veterans | Sponsor not shown (see the record) | Phase 2 | Not yet recruiting | PTSD - Post Traumatic Stress Disorder | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07777380) |
| August 19, 2026 | NCT07773935 | ONE-P TMS First Responders | Sponsor not shown (see the record) | Phase 2 | Not yet recruiting | PTSD - Post Traumatic Stress Disorder | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07773935) |
| August 18, 2026 | NCT07771530 | The Efficacy of a Pharmacological Treatment (Reboxetine Plus Ritalin) Versus Dog-Assisted Therapy in PTSD | University of Haifa | Phase 2 | Recruiting | PTSD, Posttraumatic Stress Disorder | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07771530) |
| August 14, 2026 | NCT07765693 | MDMA-AT for PTSD in Young Adults With Childhood Trauma | Sponsor not shown (see the record) | Phase 2 | Not yet recruiting | Posttraumatic Stress Disorder (PTSD) | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07765693) |
| August 4, 2026 | NCT07745569 | Assessing of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies | University of New Mexico | Phase 2 | Not yet recruiting | PTSD, PTSD - Post Traumatic Stress Disorder, Major Depression, Suicidality | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07745569) |
| July 28, 2026 | NCT07732374 | Long-Term Outcomes Following HBOT | Sponsor not shown (see the record) | Phase 2 | Recruiting | Traumatic Brain Injury, Post-Concussive Symptoms, Post-Traumatic Stress Disorder | 35 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07732374) |
| July 15, 2026 | NCT07704762 | Clinical Trial of MDMA-Assisted Therapy for Military Service Members With Posttraumatic Stress Disorder | U.S. Army Medical Research and Development Command | Phase 2 | Not yet recruiting | PTSD, Post Traumatic Stress Disorder PTSD, Post Traumatic Stress Disorder | 86 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07704762) |
| May 6, 2026 | NCT07569159 | MDMA Therapy in Veterans With PTSD | Sunstone Medical | Phase 2 | Recruiting | Post Traumatic Stress Disorder | 52 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07569159) |
| May 4, 2026 | NCT07563296 | KALM-B: Ketamine-assisted Psychotherapy (KAP) to Lessen Morbidity After Burn Injury | Sponsor not shown (see the record) | Phase 2 | Recruiting | PTSD and Trauma-related Symptoms | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07563296) |
| March 30, 2026 | NCT07499440 | Safety and Efficacy of HB-1 for Post-Traumatic Stress Disorder | HB BioTech, LLC | Phase 2 | Recruiting | PTSD, Mental Illness | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07499440) |
| March 13, 2026 | NCT07469098 | Group vs Individual MDMA-Assisted Therapy for PTSD After the October 7, 2023 Events | Sheba Medical Center | Phase 2 | Recruiting | PTSD | 168 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07469098) |
| February 17, 2026 | NCT07414537 | Remotely Administered tDCS to Improve Cognitive Function in Veterans With mTBI and PTSD Principal Investigator | VA Office of Research and Development | Phase 2 | Not yet recruiting | Cognition, Brain Injuries, Stress Disorders, Post-Traumatic | 46 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07414537) |
| January 12, 2026 | NCT07332143 | Psilocybin-Assisted Therapy | Emory University | Phase 2 | Recruiting | PTSD | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07332143) |
| January 5, 2026 | NCT07317206 | Ayahuasca, Esketamine and PTSD | University of Sao Paulo | Phase 2 | Recruiting | Posttraumatic Stress Disorder (PTSD) | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07317206) |
| December 17, 2025 | NCT07288151 | MDMA-Assisted Massed Exposure Therapy for PTSD | Emory University | Phase 2 | Recruiting | Post Traumatic Stress Disorder | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07288151) |
| November 5, 2025 | NCT07224698 | Inhaled Cannabis for Treatment of PTSD | Multidisciplinary Association for Psychedelic Studies | Phase 2 | Not yet recruiting | Post Traumatic Stress Disorder PTSD | 320 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07224698) |
| August 5, 2025 | NCT07104916 | Mindfulness-based Psilocybin Therapy for PTSD | Sponsor not shown (see the record) | Phase 2 | Recruiting | Post Traumatic Stress Disorder, Depression - Major Depressive Disorder | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07104916) |
| July 23, 2025 | NCT07079761 | Facilitation of Extinction Retention and Reconsolidation Blockade by IV Allopregnanolone in PTSD. | Massachusetts General Hospital | Phase 2 | Recruiting | Post Traumatic Stress Disorder | 96 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07079761) |
| April 24, 2025 | NCT06943404 | BXCL501 After Stress to Increase Recovery Success | University of North Carolina, Chapel Hill | Phase 2 | Recruiting | Acute Stress Reaction, Acute Stress Disorder, Post-traumatic Stress Disorder | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06943404) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| VA Office of Research and Development | 5 |
| Emory University | 3 |
| University of New Mexico | 2 |
| University of North Carolina, Chapel Hill | 2 |
| NYU Langone Health | 2 |
| Sunstone Medical | 2 |
| Pharmacotherapies for Alcohol and Substance Use Disorders Alliance | 2 |
| University of Haifa | 2 |
| Multidisciplinary Association for Psychedelic Studies | 1 |
| Bronx VA Medical Center | 1 |
| Northwestern University | 1 |
| ARQ National Psychotrauma Centre | 1 |
| University of Nebraska | 1 |
| HB BioTech, LLC | 1 |
| University of Sao Paulo | 1 |
| Tel Aviv University | 1 |
| Global Coalition for Adaptive Research | 1 |
| Baylor College of Medicine | 1 |
| The Royal's Institute of Mental Health Research | 1 |
| Stanford University | 1 |
| Texas A&M University | 1 |
| Sheba Medical Center | 1 |
| Yale University | 1 |
| The University of Texas Health Science Center at San Antonio | 1 |
| U.S. Army Medical Research and Development Command | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 36 |
| Israel | 5 |
| Canada | 4 |
| Netherlands | 2 |
| Australia | 1 |
| Brazil | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Billing services in the United States](https://specstream.ai/data/businesses/billing-services/united-states)
- [Wholesalers in the United States](https://specstream.ai/data/businesses/wholesalers/united-states)
- [Ski resorts in the United States](https://specstream.ai/data/businesses/ski-resorts/united-states)
- [Paving contractors in the United States](https://specstream.ai/data/businesses/paving-contractors/united-states)
- [Japanese restaurants in the United States](https://specstream.ai/data/businesses/japanese-restaurants/united-states)
- [Fireplace services in the United States](https://specstream.ai/data/businesses/fireplace-services/united-states)
